Correction: Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
Format: | Article |
---|---|
Language: | English |
Published: |
BMJ Publishing Group
2024-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/12/1/e007010corr1.full |
Similar Items
-
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
by: Mario Paolo Colombo, et al.
Published: (2023-10-01) -
1341 Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
by: Mario Paolo Colombo, et al.
Published: (2023-11-01) -
Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
by: Heather Lynn, et al.
Published: (2023-07-01) -
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
by: Simone Torretta, et al.
Published: (2020-02-01) -
Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents
by: Irene Conforti, et al.
Published: (2023-05-01)